Last reviewed · How we verify

NCT04909593: AIM

Study to Evaluate Automated Intensity Management in Patients Undergoing a BSC SCS Temporary Trial

Completed NA Results posted Last updated 6 December 2024
What this trial tests

NA trial testing Spinal Cord Stimulation in Chronic Pain in 21 participants. Completed in 22 November 2022.

Timeline
24 May 2021
Primary endpoint
22 November 2022
22 November 2022

Quick facts

Lead sponsorBoston Scientific Corporation
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment21
Start date24 May 2021
Primary completion22 November 2022
Estimated completion22 November 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Boston Scientific Corporation — full company profile →

Who can join

18 and older, any sex, with Chronic Pain or Intractable Pain. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Perception Threshold Primary · Programming Visit (up to 15 days post-screening)

Percent change in patient's perceiving spinal cord stimulation (i.e. Perception Threshold) when going from a reclining to sitting position in a reclining chair

GroupValue95% CI
Spinal Cord Stimulation157± 52

Sponsor's own description

The purpose of the study is to assess the feasibility of using information extracted from physiologic signals to automatically adjust stimulation in patients undergoing Spinal Cord Stimulation (SCS).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Spinal Cord Stimulation

Trials testing the same drug.

Other recruiting trials for Chronic Pain

Currently open trials in the same condition.

Other Boston Scientific Corporation trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04909593.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing